NDUFA5 and fatty liver disease: In conclusions, our findings supported that miR‐33a/NDUFA5 axis was an important mediator of hepatocyte mitochondrial function, and the therapeutic benefits implied miR‐33a antisense had the potential clinical application in combating fatty liver disease.